ascopubs.org

Prospective observational study to evaluate efficacy and safety of immunotherapy (IO) in elderly (eld) patients (pts) with non-small cell lung cancer (NSCLC) undergoing ...

Diffusing capacity for carbon monoxide (DLCO) change and outcome in advanced non-small cell lung cancer (aNSCLC) treated with immune checkpoint inhibitors (ICIs). This is an ASCO Meeting Abstract from ...
Healthline

Types of Medical Studies: Your Guide

Medical research shapes healthcare every day, but not all studies are created equal. Knowing the differences can help you feel more confident reading health information online and understanding what ...
ascopubs.org

Feasibility and efficacy of oral 5-FU in combination with pembrolizumab and cisplatin as first-line therapy for recurrent/metastatic head and neck squamous cell carcinoma: A ...

Camrelizumab plus chemotherapy or apatinib in the first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma: A double-cohort phase II study. This is an ASCO Meeting ...

AbbVie Completes Real World Upadacitinib Study in China: What Investors Should Watch

Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter AbbVie (ABBV) has completed a real world study in China tracking how its oral drug ...

Pfizer’s ODEN Study Update: Real-World Data on Tofacitinib in Ulcerative Colitis

The treatment under review is tofacitinib, an oral drug for adults with ulcerative colitis. It targets inflammation and is already approved, so this study focuses on how it performs outside controlled ...